Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210032715 210008897 1.64 63.7 Not known (9) 2014-12-15 2015-03-16 UKALL14- Cons Cycle 2 N N 210016850 UKALL2014
210032716 210019620 1.85 63 Palliative (P) null 2016-04-14 UKALL14- Cons Cycle 3 Y null 210016857 UKALL2014
210032717 210008905 1.75 88 Curative (C) 2015-12-12 2015-12-25 UKALL14- Maintenance Y Y 210016869 UKALL2014
210032718 210008906 1.78 108 Curative (C) 2015-02-01 2015-10-02 UKALL14- Intens/CNS Proph Y N 210016869 UKALL2014
210032719 210008908 1.83 98.7 Curative (C) 2015-07-08 2015-07-18 UKALL14- Ph 2 Induction Y N 210016886 UKALL2014
210032720 210008913 1.77 94.2 Curative (C) null 2016-06-03 UKALL14- Maintenance 1 null 210016897 UKALL2014
210032721 210008914 1.83 60.7 Palliative (P) null 2014-11-15 UKALL14- Maintenance N null 210016914 UKALL2014
210032722 210008917 1.68 84.8 Disease modification (D) 2015-10-07 2015-10-07 UKALL14- Maintenance N null 210016920 UKALL2014
210032723 210008918 0 57.2 Curative (C) 2013-12-11 2014-07-22 UKALL14- FMC (1 day) Conditioning 02 N 210016930 UKALL2014
210032724 210008920 0 87.3 Disease modification (D) 2017-08-12 2018-01-11 UKALL 14 TRIAL Y N 210016939 UKALL2014
210032725 210008926 1.82 91.2 Curative (C) 2017-03-03 2017-03-04 UKALL14- Ph 1 Induction N N 210016943 UKALL2014
210032726 210008928 1.72 86.8 null 2012-07-23 2014-06-18 UKALL14- Maintenance 1 N 210016965 UKALL2014
210032727 210026519 1.63 106 Curative (C) null 2016-03-03 UKALL14- Maintenance Y N 210016982 UKALL2014
210032728 210008932 1.68 74.2 Curative (C) null 2017-10-11 UKALL14- Cons Cycle 2 N N 210016984 UKALL2014
210032729 210008934 1.76 null Curative (C) 2015-03-23 2015-07-31 UKALL14- Maintenance 01 N 210016990 UKALL2014
210032731 210008939 1.82 69.5 Not known (9) 2015-04-13 2015-04-18 UKALL14- FMC (1 day) Conditioning 1 N 210017000 UKALL2014
210032732 210008941 1.85 90 Curative (C) 2015-01-19 2017-10-31 UKALL 14 TRIAL Y N 210017005 UKALL2014
210032733 210036026 1.71 94.2 Curative (C) null 2013-08-29 UKALL14- FMC (2 day) Conditioning Y null 210017006 UKALL2014
210032734 210008944 1.68 79.4 Curative (C) 2014-06-01 2014-06-03 UKALL14- Intens/CNS Proph 01 null 210017034 UKALL2014
210032735 210008947 1.76 83.8 Curative (C) 2014-07-15 2014-10-26 UKALL14- Ph 2 Induction 02 null 210017038 UKALL2014
210032736 210008949 1.83 86.9 Disease modification (D) 2014-12-11 2015-01-14 UKALL14- Ph 2 Induction + Imatinib Y N 210017042 UKALL2014
210032737 210008951 1.81 77.8 Curative (C) 2014-04-25 2014-08-14 UKALL14- Ph 2 Induction 01 N 210017044 UKALL2014
210032738 210026534 1.82 null Curative (C) 2013-12-29 2014-03-30 UKALL14- Maintenance Y null 210017053 UKALL2014
210032739 210008955 1.75 78.6 Curative (C) 2016-07-21 2016-07-24 UKALL14- Maintenance 01 N 210017066 UKALL2014
210032740 210026537 1.76 78 Curative (C) 2016-04-18 2016-04-24 UKALL14- Ph 2 Induction + Imatinib Y Y 210017071 UKALL2014
210032741 210026538 null 50 Neo-adjuvant (N) 2016-09-11 2017-02-06 UKALL14- Maintenance Y N 210017073 UKALL2014
210032742 210030659 1.76 null Curative (C) 2013-12-07 2014-03-29 UKALL 14 TRIAL 01 N 210017081 UKALL2014
210032743 210008962 1.88 77.5 Unknown (U) 2013-08-06 2013-12-26 UKALL14- Intens/CNS Proph 01 N 210017102 UKALL2014
210032744 210008965 1.87 60.5 Curative (C) 2014-01-19 2014-06-21 UKALL14- Cons Cycle 2 02 N 210017106 UKALL2014
210032745 210030661 1.46 86.9 Curative (C) 2016-09-09 2016-10-16 UKALL14- Maintenance Y N 210017119 UKALL2014
210032746 210008972 1.75 61.7 Curative (C) 2018-06-27 2018-07-01 UKALL14- Intens/CNS Proph 01 N 210017129 UKALL2014
210032747 210030665 1.85 70 Curative (C) 2018-05-19 2018-06-01 UKALL14- Cons Cycle 2 N Y 210017141 UKALL2014
210032748 210008978 1.76 120 Palliative (P) 2015-12-30 2015-12-30 UKALL 14 TRIAL 02 N 210017152 UKALL2014
210032749 210008984 1.9 84 Palliative (P) 2015-12-31 2016-03-21 UKALL14- Maintenance Y N 210017169 UKALL2014
210032750 210008987 1.66 75.5 Curative (C) 2015-04-10 2015-04-10 UKALL14- Maintenance 1 N 210017172 UKALL2014
210032751 210008989 1.75 null Curative (C) 2014-06-26 2014-06-27 UKALL14- Maintenance N N 210017183 UKALL2014
210032752 210030670 1.76 94.499 Curative (C) null 2018-04-24 UKALL14- Intens/CNS Proph N N 210017197 UKALL2014
210032753 210008992 1.94 61 Curative (C) 2015-01-10 2015-01-10 UKALL14- Intens/CNS Proph 2 null 210017201 UKALL2014
210032754 210019681 0 67 Curative (C) 2017-10-22 2017-10-22 UKALL14- Intens/CNS Proph Y N 210017207 UKALL2014
210032755 210008996 1.65 81 Curative (C) null 2013-04-18 UKALL14- Maintenance Y N 210017210 UKALL2014
210032756 210008999 1.89 100 Disease modification (D) 2014-05-14 2014-06-17 UKALL14- Cons Cycle 1 2 null 210017238 UKALL2014
210032757 210009003 null 73.1 Curative (C) 2015-10-07 2015-10-13 UKALL14- Cons Cycle 3 1 null 210017255 UKALL2014
210032758 210033247 1.78 67 Curative (C) 2017-04-27 2017-08-02 UKALL14- Intens/CNS Proph +Imatinib 2 null 210017263 UKALL2014
210032759 210009007 1.74 46 Curative (C) null 2016-09-27 UKALL14- Intens/CNS Proph +Imatinib N N 210017279 UKALL2014
210032760 210009008 1.6 57.7 Neo-adjuvant (N) 2016-10-02 2016-10-03 UKALL 14 TRIAL N N 210017279 UKALL2014
210032761 210009011 1.77 132 Curative (C) 2016-04-26 2016-05-03 UKALL14- Ph 2 Induction 02 N 210017313 UKALL2014
210032762 210019695 1.71 84.9 Neo-adjuvant (N) 2017-12-27 2017-12-27 UKALL14- Cons Cycle 1 02 N 210017326 UKALL2014
210032763 210009016 1.77 80.8 Palliative (P) 2018-12-02 2018-12-02 UKALL14- Cons Cycle 3 02 N 210017334 UKALL2014
210032765 210009022 1.46 73.6 null 2017-12-18 2018-04-02 UKALL14- Ph 2 Induction + Imatinib N N 210017387 UKALL2014
210032766 210019705 1.84 63.1 Curative (C) 2013-08-29 2013-12-05 UKALL14- Maintenance Y N 210017394 UKALL2014